Last Updated: May 12, 2026

Suppliers and packagers for jaythari


✉ Email this page to a colleague

« Back to Dashboard


jaythari

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Zydus Lifesciences JAYTHARI deflazacort TABLET;ORAL 219254 ANDA Zydus Pharmaceuticals (USA) Inc. 70710-1749-1 1 BOTTLE in 1 CARTON (70710-1749-1) / 100 TABLET in 1 BOTTLE 2025-06-12
Zydus Lifesciences JAYTHARI deflazacort TABLET;ORAL 219254 ANDA Zydus Pharmaceuticals (USA) Inc. 70710-1750-3 1 BOTTLE in 1 CARTON (70710-1750-3) / 30 TABLET in 1 BOTTLE 2025-06-12
Zydus Lifesciences JAYTHARI deflazacort TABLET;ORAL 219254 ANDA Zydus Pharmaceuticals (USA) Inc. 70710-1751-3 1 BOTTLE in 1 CARTON (70710-1751-3) / 30 TABLET in 1 BOTTLE 2025-06-12
Zydus Lifesciences JAYTHARI deflazacort TABLET;ORAL 219254 ANDA Zydus Pharmaceuticals (USA) Inc. 70710-1752-3 1 BOTTLE in 1 CARTON (70710-1752-3) / 30 TABLET in 1 BOTTLE 2025-06-12
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for jaythari

Last updated: April 25, 2026

Who Supplies the Pharmaceutical Drug “JAYTHARI”?

No complete, reliable supplier dataset for the pharmaceutical drug “JAYTHARI” is available from the information provided. Without verifiable sourcing (e.g., label/packaging, approved product master data, or regulator-linked commercial supply records), listing suppliers would risk being inaccurate.

What Counts as an Acceptable “Supplier” Source for JAYTHARI?

A defensible supplier list must be traceable to one of the following evidence classes:

  • Regulatory/label-linked supply chain: manufacturer and marketing authorization holder data tied to the exact product name and strength.
  • Commercial packaging evidence: carton/label labeling that names manufacturer, marketing entity, and packer/distributor.
  • Authoritative product registration records: country-specific registration that includes full legal entity names and addresses for each site tied to the marketed product.

Why Supplier Identification Cannot Be Completed From the Given Input

“JAYTHARI” is not sufficient on its own to uniquely identify:

  • the active ingredient (and salt form),
  • the strength and dosage form,
  • the country/market where it is sold,
  • the exact legal product name used in regulatory filings and on labels.

Supplier mapping requires those disambiguators because multiple products can share brand-like naming, and suppliers change by market and by strength.

Key Takeaways

  • A precise supplier list for “JAYTHARI” cannot be produced from the provided information.
  • Supplier identification must be grounded in label- or regulator-linked records tied to the exact product identity (ingredient, strength, dosage form, and market).
  • Without those identifiers, any supplier names would be speculative.

FAQs

  1. What supplier categories matter for a marketed drug?
    Manufacturer of record, marketing authorization holder, packer/repacker, and distributor are the standard categories tied to product accountability.

  2. Does “JAYTHARI” alone identify a single product?
    No. Brand-like names often map to different formulations, strengths, or markets.

  3. Which documents usually name the suppliers?
    Product label/carton text, regulatory product registration entries, and product master data maintained by health authorities.

  4. Do suppliers differ by country?
    Yes. The marketed product’s manufacturing and distribution chain can vary by jurisdiction.

  5. Can suppliers be inferred from the active ingredient only?
    Not reliably for a brand product, because manufacturing sites, packaging sites, and legal entities can differ by strength and market.

References

[1] No sources were provided in the request.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.